6504 ORAL Safety and Efficacy of Epirubicin, Cisplatin, and Capecitabine (ECX) Plus Rilotumumab (R) as First-line Treatment for Unresectable Locally Advanced (LA) or Metastatic (M) Gastric or Esophagogastric Junction (EGJ) Adenocarcinoma

European Journal of Cancer ◽

10.1016/s0959-8049(11)71815-9 ◽

2011 ◽

Vol 47 ◽

pp. S443 ◽

Cited By ~ 13

Author(s):

T. Iveson ◽

R.C. Donehower ◽

I. Davidenko ◽

S. Tjulandin ◽

A. Deptala ◽

...

Keyword(s):

Esophagogastric Junction ◽

Locally Advanced ◽

Line Treatment ◽

First Line ◽

Safety And Efficacy ◽

First Line Treatment

Download Full-text

Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial

BMC Cancer ◽

10.1186/s12885-020-07251-z ◽

2020 ◽

Vol 20 (1) ◽

Cited By ~ 2

Author(s):

Haiping Jiang ◽

Yulong Zheng ◽

Jiong Qian ◽

Chenyu Mao ◽

Xin Xu ◽

...

Keyword(s):

Clinical Trial ◽

Gastroesophageal Junction ◽

Locally Advanced ◽

Line Treatment ◽

First Line ◽

Safety And Efficacy ◽

Phase Ib ◽

Gastroesophageal Junction Adenocarcinoma ◽

First Line Treatment

Download Full-text

Safety and efficacy of vinorelbine in combination with pertuzumab and trastuzumab for first-line treatment of patients with HER2-positive locally advanced or metastatic breast cancer: VELVET Cohort 1 final results

Breast Cancer Research ◽

10.1186/s13058-016-0773-6 ◽

2016 ◽

Vol 18 (1) ◽

Cited By ~ 27

Author(s):

Edith A. Perez ◽

José Manuel López-Vega ◽

Thierry Petit ◽

Claudio Zamagni ◽

Valerie Easton ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Locally Advanced ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Her2 Positive ◽

Safety And Efficacy ◽

First Line Treatment

Download Full-text

Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC

Case Medical Research ◽

10.31525/ct1-nct03997123 ◽

2019 ◽

Author(s):

Keyword(s):

Locally Advanced ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)

Case Medical Research ◽

10.31525/ct1-nct04248829 ◽

2020 ◽

Author(s):

Keyword(s):

Clinical Trial ◽

Egfr Mutation ◽

Locally Advanced ◽

Line Treatment ◽

First Line ◽

Metastatic Nsclc ◽

First Line Treatment

Download Full-text

A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis

Annals of Oncology ◽

10.1016/j.annonc.2021.01.065 ◽

2021 ◽

Author(s):

A. Brufsky ◽

S.B. Kim ◽

Ž. Zvirbule ◽

A. Eniu ◽

J. Mebis ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Trial ◽

Phase Ii ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Locally Advanced ◽

Line Treatment ◽

First Line ◽

Primary Analysis ◽

First Line Treatment

Download Full-text

Adriamycin and Cis-Platinum as First-Line Treatment in Unresectable Locally Advanced or Metastatic Adult Soft-Tissue Sarcomas

American Journal of Clinical Oncology ◽

10.1097/01.coc.0000071467.96942.2f ◽

2004 ◽

Vol 27 (3) ◽

pp. 307-311 ◽

Cited By ~ 1

Author(s):

Haralabos P. Kalofonos ◽

Dimitrios Bafaloukos ◽

Theodoros G. Kourelis ◽

Michalis V. Karamouzis ◽

Panagiotis Megas ◽

...

Keyword(s):

Soft Tissue ◽

Locally Advanced ◽

Soft Tissue Sarcomas ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

A Randomized Phase II Trial of Pemetrexed plus Irinotecan (ALIRI) versus Leucovorin-Modulated 5-FU plus Irinotecan (FOLFIRI) in First-Line Treatment of Locally Advanced or Metastatic Colorectal Cancer

Oncology ◽

10.1159/000120626 ◽

2007 ◽

Vol 73 (1-2) ◽

pp. 9-20 ◽

Cited By ~ 11

Author(s):

Craig Underhill ◽

David Goldstein ◽

Vera A. Gorbounova ◽

Mikhail Y. Biakhov ◽

Igor S. Bazin ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

Immunochemotherapy as First-line Treatment for Locally Advanced or Metastatic Squamous Non–Small Cell Lung Cancers

JAMA Oncology ◽

10.1001/jamaoncol.2021.3372 ◽

2021 ◽

Author(s):

Shujie Huang ◽

Zhen Gao ◽

Guibin Qiao

Keyword(s):

Locally Advanced ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Lung Cancers ◽

First Line Treatment

Download Full-text

A Retrospective Study of the Safety and Efficacy of a First-Line Treatment with Modified FOLFOX-4 in Unresectable Advanced or Recurrent Gastric Cancer Patients

Chemotherapy ◽

10.1159/000345742 ◽

2012 ◽

Vol 58 (5) ◽

pp. 411-418 ◽

Cited By ~ 8

Author(s):

Yung-Sung Yeh ◽

Hsiang-Lin Tsai ◽

Cheng-Jen Ma ◽

Deng-Chyang Wu ◽

Chien-Yu Lu ◽

...

Keyword(s):

Gastric Cancer ◽

Retrospective Study ◽

Cancer Patients ◽

Line Treatment ◽

First Line ◽

Safety And Efficacy ◽

Recurrent Gastric Cancer ◽

Gastric Cancer Patients ◽

First Line Treatment

Download Full-text

EECONOMIC EVALUATION OF AFATINIB AS THE FIRST LINE TREATMENT IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC) LOCALLY ADVANCED OR METASTATIC IN PRESENCE OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATIONS IN A MEXICAN INSTITUTIONAL CONTEXT

Value in Health ◽

10.1016/j.jval.2015.03.1179 ◽

2015 ◽

Vol 18 (3) ◽

pp. A307

Author(s):

J.L. Huicochea-Bartelt ◽

X. Burbano ◽

E. Palacios ◽

S. Herran ◽

C. Valencia

Keyword(s):

Locally Advanced ◽

Growth Factor Receptor ◽

Institutional Context ◽

Small Cell ◽

Egfr Mutations ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Epidermal Growth ◽

First Line Treatment

Download Full-text